Budget Impact Analysis Of Biosimilar Rituximab (CT-P10) For The Treatment Of Diffuse Large B-Cell And Follicular Lymphoma In The 28 EU Member States
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.850
https://www.valueinhealthjournal.com/article/S1098-3015(17)31184-1/fulltext
Title :
Budget Impact Analysis Of Biosimilar Rituximab (CT-P10) For The Treatment Of Diffuse Large B-Cell And Follicular Lymphoma In The 28 EU Member States
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31184-1&doi=10.1016/j.jval.2017.08.850
First page :
A548
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
809